Skip to content
healthcare.dev

QUDEXY XR

NDC 0245-1075, Topiramate, capsule, extended release, from Upsher-Smith Laboratories, LLC.

Product NDC
0245-1075
Status
Listed
Labeler
Upsher-Smith Laboratories, LLC
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA205122
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0245-1075 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOPIRAMATE150 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
0245-1075-30002451075301 BOTTLE in 1 CARTON (0245-1075-30) / 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
0245-1075-90002451075901 BOTTLE in 1 CARTON (0245-1075-90) / 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/46f54677-3a22-4c38-9b92-923020164e15

Use it

Look up 0245-1075 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0245-1075 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0245-1075. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.